Get started

Navidea Biopharmaceuticals, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals

NAVB chart

Key stats

Market capitalization
9.108MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.2841USD
Net income
−15.177MUSD
Revenue
65.652KUSD
Shares float
66.185M
Beta
0.51

About Navidea Biopharmaceuticals, Inc.

Sector
Health Technology
Industry
Medical Specialties
Headquarters
Dublin
Website
navidea.com
Employees (FY)
15
Founded
1983
ISIN
US63937X2027

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.

Ideas

$NAVB is gonna fall todayPupm&Dump trading strategy idea. $NAVB is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $2,06; stop-loss — $2,18; take-profit — $1,82. Do not view th
NAVBNAVB - NAVIDEA BIOPHARMACEUTICALS has complete a very long belly formation and recently we have seen new accumulation. Above 4.87 a break out would carry the stock to 6.50 area. I believe there is news coming from the company and that would increase the price and it may be the for the stock acc
Long
1
upbeat data on an ongoing phase 2 trialThe company said late Thursday that preliminary results of a second interim analysis of its NAV3-31 Phase 2B study further corroborates its hypotheses that Tc99m tilmanocept imaging can provide robust, quantitative imaging in healthy controls and in patients with active rheumatoid arthritis (RA), an
Navidea Biopharmaceuticals, Buy RatingH.C. Wainwright reiterated a Buy rating on Navidea, with a price target of $4.00. The company’s shares closed last Monday at $0.98. Company profile Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operat
Long
NAVB - Retracement - MA Retest Coming UpNavidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH. SH
Long
Could this be a breakout?Navidea has been around a long time, it started around $20 but has been under a dollar for a few years. They made a big sale mid-2017 which more or less wiped out their debts and their conference call last November gave the impression that their latest drug is a game changer for them. After last w
NAVB pulse wave rise...The exchange rate is ahead of a significant increase. The target price for the first wave structure is 0.3785. This is a D1 ATR axis level. We expect a level of adjustment from this level, with a support level of 0.1700 usd. Then a double upward wave structure may develop with a target price of 0.57
Long

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
No revenue here
This company hasn't generated any revenue in the last financial year
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.3Good
Learn more

See all brokers